地塞米松与慢性术后疼痛:减少论思维的钟摆
本文评述PADDI试验关于单次术前地塞米松安全性的后续分析,包括已发表亚组研究和本期ENIGMA-II慢性疼痛数据库回顾分析。作者认为现有数据足以说明单次地塞米松安全有效,但原PADDI报告中慢性术后疼痛增加提示其发生机制复杂且可能涉及免疫机制,并呼吁对其他抗炎药开展设计良好的临床试验。
要点
- 单次术前地塞米松被PADDI后续分析认为安全有效。
- 原PADDI报告曾显示单次地塞米松增加慢性术后疼痛发生率。
- 慢性术后疼痛发生机制复杂,可能涉及免疫机制,需高质量试验验证。
核心结论
- PADDI研究者提供的数据足以让作者相信单次术前地塞米松是安全有效的。
- 原PADDI报告中单次地塞米松增加慢性术后疼痛发生率,提示慢性术后疼痛发生机制复杂且可能涉及免疫机制。
- 需开展设计良好的临床试验评估其他常规用于长期术后疼痛管理的抗炎药。
研究设计与样本
- 本文为针对PADDI试验慢性术后疼痛次要结局后续分析的评述文章。
- PADDI研究者以两种方式分析预设次要结局:已发表于本刊的亚组研究和本期基于ENIGMA-II慢性疼痛数据库的回顾性分析。
主要发现
- 原PADDI报告显示单次地塞米松增加慢性术后疼痛这一次要结局的发生率。
- 后续亚组研究和ENIGMA-II数据库回顾分析使作者认为单次地塞米松安全有效。
- 原PADDI中慢性术后疼痛增加的原因尚不明确,可能涉及免疫机制。
临床怎么用
- 基于PADDI后续分析,单次术前地塞米松可被认为安全有效。
- 应关注慢性术后疼痛这一以患者为中心的不良功能结局,并审慎评估其他围术期抗炎药。
局限性
- 原文未报告具体样本量、效应量、置信区间或P值。
- 关于地塞米松是否增加慢性术后疼痛,原文提出尚需进一步研究明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reductionist thinking results in the bulk of anaesthesia trial designs being a single intervention to address what are in fact complex processes. The Perioperative Administration of Dexamethasone and Infection (PADDI) trial assessed the safety of a single preoperative dose of dexamethasone. Surprising to most, in the original report, a single dose of dexamethasone increased the incidence of the secondary outcome chronic postsurgical pain. Was this a chance finding or does dexamethasone increase chronic postsurgical pain? In an attempt to address this question, the PADDI investigators have now analysed this prespecified secondary outcome in two ways: as a substudy published earlier in this Journal, and as a retrospective analysis of the ENIGMA-II chronic pain database in this issue of the Journal. The PADDI investigators have now presented enough data to convince us that indeed a single dose of dexamethasone is safe and effective. However, the increase in chronic postsurgical pain seen in the original PADDI publication highlights the complexities, and the possible immunologic mechanisms, behind the genesis of chronic postsurgical pain. These publications from the PADDI group raise questions about other anti-inflammatory agents we use regularly for long-term postoperative pain management, and highlights the need for well-designed clinical trials to address this critically important patient-centred adverse functional outcome.
引用
- Buckley DN, Beattie WS. Dexamethasone and chronic postsurgical pain: the pendulum meets reductionistic thinking. Br J Anaesth. 2024. PMID: 38744550. doi:10.1016/j.bja.2024.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。